BackShanghai Haohai Biological Technology , Ltd. Overview

Shanghai Haohai Biological Technology , Ltd. Total Assets

Latest total assets for 688366.SS: $6.6B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$6.56B
↓ 8.72% YoYΔ $-626.94M vs prior year quarter

Peer trimmed avg / median

Loading

Shanghai Haohai Biological Technology , Ltd. Total Assets History

Loading

Shanghai Haohai Biological Technology , Ltd. vs. peers: Total Assets Comparison

Loading

Shanghai Haohai Biological Technology , Ltd. Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Shanghai Haohai Biological Technology , Ltd. (688366.SS) FAQ

As of the most recent data (June 2026), 688366.SS shows a total assets of $6.6B. That compares with $7.2B in the prior-year period — down 8.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 688366.SS's total assets is now $6.6B (was $7.2B) — a 8.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Shanghai Haohai Biological Technology , Ltd. is outperforming or lagging.

Tracking 688366.SS's total assets over time shows whether Shanghai Haohai Biological Technology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $6.6B That compares with $7.2B in the prior-year period — down 8.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Shanghai Haohai Biological Technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $6.6B) with ownership activity and broader fundamentals.

Shanghai Haohai Biological Technology , Ltd.'s total assets is $6.6B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.